BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 15867494)

  • 1. Severity and outcome of HIV-associated Pneumocystis pneumonia containing Pneumocystis jirovecii dihydropteroate synthase gene mutations.
    Crothers K; Beard CB; Turner J; Groner G; Fox M; Morris A; Eiser S; Huang L
    AIDS; 2005 May; 19(8):801-5. PubMed ID: 15867494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of dihydropteroate synthase genotypes before and after the introduction of combined antiretroviral therapy and their influence on the outcome of Pneumocystis pneumonia in HIV-1-infected patients.
    Alvarez-Martínez MJ; Miró JM; Valls ME; Mas J; de la Bellacasa JP; Sued O; Solé M; Rivas PV; de Lazzari E; Benito N; García F; Agustí C; Wilson PE; Gatell JM; Jiménez de Anta MT; Meshnick SR; Moreno A
    Diagn Microbiol Infect Dis; 2010 Sep; 68(1):60-5. PubMed ID: 20727472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia.
    Helweg-Larsen J; Benfield TL; Eugen-Olsen J; Lundgren JD; Lundgren B
    Lancet; 1999 Oct; 354(9187):1347-51. PubMed ID: 10533864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dihydropteroate synthase (DHPS) gene mutation study in HIV-Infected Indian patients with Pneumocystis jirovecii pneumonia.
    Tyagi AK; Mirdha BR; Luthra K; Guleria R; Mohan A; Singh UB; Samantaray JC; Dar L; Iyer VK; Chaudhry R
    J Infect Dev Ctries; 2010 Nov; 4(11):761-6. PubMed ID: 21252456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumocystis jirovecii pneumonia in Spanish HIV-infected patients in the combined antiretroviral therapy era: prevalence of dihydropteroate synthase mutations and prognostic factors of mortality.
    Alvarez-Martínez MJ; Moreno A; Miró JM; Valls ME; Rivas PV; de Lazzari E; Sued O; Benito N; Domingo P; Ribera E; Santín M; Sirera G; Segura F; Vidal F; Rodríguez F; Riera M; Cordero ME; Arribas JR; Jiménez de Anta MT; Gatell JM; Wilson PE; Meshnick SR;
    Diagn Microbiol Infect Dis; 2008 Sep; 62(1):34-43. PubMed ID: 18554841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Prevalence of Pneumocystis jirovecii Dihydropteroate Synthase Gene Mutations in Patients with a First Episode of Pneumocystis Pneumonia in Santiago, Chile, and Clinical Response to Trimethoprim-Sulfamethoxazole Therapy.
    Ponce CA; Chabé M; George C; Cárdenas A; Durán L; Guerrero J; Bustamante R; Matos O; Huang L; Miller RF; Vargas SL
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low prevalence of Pneumocystis pneumonia (PCP) but high prevalence of pneumocystis dihydropteroate synthase (dhps) gene mutations in HIV-infected persons in Uganda.
    Taylor SM; Meshnick SR; Worodria W; Andama A; Cattamanchi A; Davis JL; Yoo SD; Byanyima P; Kaswabuli S; Goodman CD; Huang L;
    PLoS One; 2012; 7(11):e49991. PubMed ID: 23166805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of dihydropteroate synthase mutants in HIV-infected South African children with Pneumocystis jiroveci pneumonia.
    Zar HJ; Alvarez-Martinez MJ; Harrison A; Meshnick SR
    Clin Infect Dis; 2004 Oct; 39(7):1047-51. PubMed ID: 15472859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel dihydropteroate synthase gene mutation in Pneumocystis jirovecii among HIV-infected patients in India: Putative association with drug resistance and mortality.
    Singh Y; Mirdha BR; Guleria R; Kabra SK; Mohan A; Chaudhry R; Kumar L; Dwivedi SN; Agarwal SK
    J Glob Antimicrob Resist; 2019 Jun; 17():236-239. PubMed ID: 30658203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and prevalence of dihydropteroate synthase gene mutations in Pneumocystis jirovecii-infected AIDS patients from low endemic areas of China.
    Zhu M; Ye N; Xu J
    PLoS One; 2020; 15(9):e0238184. PubMed ID: 32911508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of P carinii pneumonia in patients with HIV-1: a prospective study.
    Navin TR; Beard CB; Huang L; del Rio C; Lee S; Pieniazek NJ; Carter JL; Le T; Hightower A; Rimland D
    Lancet; 2001 Aug; 358(9281):545-9. PubMed ID: 11520525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pneumocystis jirovecii genotype associated with increased death rate of HIV-infected patients with pneumonia.
    Rabodonirina M; Vaillant L; Taffé P; Nahimana A; Gillibert RP; Vanhems P; Hauser PM
    Emerg Infect Dis; 2013 Jan; 19(1):21-8; quiz 186. PubMed ID: 23260763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dihydropteroate Synthase (DHPS) Gene Mutations and Mitochondrial Large Subunit (mtLSU) rRNA Genotype Variations in Pneumocystis jirovecii Strains].
    Gülbudak H; Öztürk C; Kuyugöz S; Tezcan Ülger S
    Mikrobiyol Bul; 2021 Jan; 55(1):41-52. PubMed ID: 33590980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and clinical relevance of Pneumocystis jirovecii Frenkel, 1976 dihydropteroate synthase gene mutations.
    Matos O; Esteves F
    Parasite; 2010 Sep; 17(3):219-32. PubMed ID: 21073145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumocystis jirovecii dihydropteroate synthase (DHPS) genotypes in non-HIV-immunocompromised patients: a tertiary care reference health centre study.
    Tyagi AK; Mirdha BR; Luthra K; Guleria R; Mohan A; Singh UB; Samantaray JC; Dar L; Iyer VK; Sreenivas V
    Med Mycol; 2011 Feb; 49(2):167-71. PubMed ID: 20718608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low prevalence of DHFR and DHPS mutations in Pneumocystis jirovecii strains obtained from a German cohort.
    Suárez I; Roderus L; van Gumpel E; Jung N; Lehmann C; Fätkenheuer G; Hartmann P; Plum G; Rybniker J
    Infection; 2017 Jun; 45(3):341-347. PubMed ID: 28303545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of dihydropteroate synthase mutations in Pneumocystis jirovecii isolated from patients with Pneumocystis pneumonia in South Africa.
    Dini L; du Plessis M; Frean J; Fernandez V
    J Clin Microbiol; 2010 Jun; 48(6):2016-21. PubMed ID: 20351205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of DHPS and DHFR genes of Pneumocystis jirovecii in Thai HIV-infected patients.
    Siripattanapipong S; Leelayoova S; Mungthin M; Worapong J; Tan-Ariya P
    Med Mycol; 2008 Jun; 46(4):389-92. PubMed ID: 18415849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotyping of Pneumocystis jiroveci pneumonia in Italian AIDS patients. Clinical outcome is influenced by dihydropteroate synthase and not by internal transcribed spacer genotype.
    Valerio A; Tronconi E; Mazza F; Fantoni G; Atzori C; Tartarone F; Duca P; Cargnel A
    J Acquir Immune Defic Syndr; 2007 Aug; 45(5):521-8. PubMed ID: 17558331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of mutations in dihydropteroate synthase in Pneumocystis jirovecii pneumonia among non-HIV-infected patients.
    Liao TY; Huang YT; Lee TF; Hsueh PR; Yu CJ; Chien JY
    Int J Antimicrob Agents; 2024 Jan; 63(1):107019. PubMed ID: 37925109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.